The Prostate Cancer Foundation Challenges Americans To Kick The New Year Off Right By Taking The 21 in 21 Pledge
World s leading prostate cancer research non-profit encourages people to take simple science-based actions to raise awareness about how healthy lifestyles can help reduce cancer risk
News provided by
Share this article
Share this article
LOS ANGELES, Dec. 22, 2020 /PRNewswire/ The Prostate Cancer Foundation (PCF) challenges Americans to show their support for men affected by prostate cancer and raise awareness about the link between healthy lifestyles and reduced cancer risk by making a New Year s resolution to make 21 simple, healthy lifestyle changes in 2021.
Prostate cancer regulator plays role in COVID-19, providing a promising treatment lead
ANN ARBOR, Michigan By taking a lesson from prostate cancer, researchers now have a promising lead on a treatment for COVID-19.
Two proteins, ACE2 and TMPRSS2, help the coronavirus gain entry and replicate within cells. TMPRSS2 is well-known to Arul Chinnaiyan, M.D., Ph.D. His lab discovered that TMPRSS2 fuses with the ETS gene to drive more than half of all prostate cancers. They also knew that TMPRSS2 was regulated by the androgen receptor.
So when cancer research shut down in the spring, Chinnaiyan s lab turned its attention to the coronavirus. With a grant from the National Cancer Institute, the team used its existing knowledge and resources to determine how TMPRSS2 was regulated in the lungs.
Our Gift to Our Communities
In a year like no other, Northcentral University has taken a different approach to its year-end employee recognition
News provided by
Share this article
Share this article
LA JOLLA, Calif., Dec. 17, 2020 /PRNewswire/ Like many companies and organizations, Northcentral University likes to thank its employees with a gift at the end of the year. As a virtual university, our faculty and staff live everywhere, and we usually mail them a small token to thank them for their hard work during the year, said Molly Gutterud, vice president of communications and advancement. Gutterud s team oversees university communications and community relations.
UCLA Jonsson Comprehensive Cancer Center
Dr. Jeremie Calais
December 16, 2020
Dr. Jeremie Calais, assistant professor of nuclear medicine and theranostics in the department of molecular and medical pharmacology at the David Geffen School of Medicine at UCLA, is one of 26 researchers to be named a 2020 Young Investigator by the Prostate Cancer Foundation.
In recognition of innovative prostate cancer research, the Young Investigator Award is given to the next generation of cancer researchers who are committed to advancing the prostate cancer field.
Calais, who is trained in nuclear medicine and cancer imaging, was awarded the Larry Ruvo-PCF Young Investigator Award and $225,000 to help support his work investigating a PET imaging tracer that targets the fibroblast activation protein, or FAP, expressed on fibroblasts within the tumor stroma or on cancer-associated fibroblasts. Validating a biomarker for FAP expression may help guide treatment decisions for men with prostate cancer,
The Prostate Cancer Foundation And Cancer Research Innovation In Science Announce 2020 Young Investigator Award Winners
News provided by
Share this article
Share this article
LOS ANGELES, Dec. 16, 2020 /PRNewswire/ The Prostate Cancer Foundation (PCF) and Cancer Research Innovation in Science (CRIS) today announced two new CRIS Cancer Foundation-PCF Young Investigator Awards. The awards, each in the amount of $250,000, are granted to future research leaders at two of the United Kingdom s leading cancer research institutions who will keep the field of prostate cancer research vibrant with new ideas.
Established by the PCF in 2008, the Young Investigator Awards offer career and project support for young (generally 35 and younger), proven investigators in postdoctoral fellowships or who have recently achieved junior faculty positions and are committing their lives to the field of prostate cancer. Each proposal submitted to the PCF undergoes a rigorous peer-review process that a